- Eschewing a straw poll from shareholders because of the risk in triggering a poison pill provision, Pershing Square's Bill Ackman now wants a more definitive vote on removing the bulk of the Allergan (AGN +2.6%) board. A special meeting on the issue could happen as early as August. Pershing Square needs consent from at least 25% of the firm's shares to hold the meeting. Mr. Ackman says he has the votes to move forward.
- Related ticker: (VRX +1.8%)
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Nasdaq.com (Tue, 9:00AM)
at CNBC.com (Feb 18, 2015)
at CNBC.com (Feb 10, 2015)
at CNBC.com (Jan 26, 2015)
at Nasdaq.com (Jan 21, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs